FRESENIUS KABI PHARMA PORTUGAL, LDA. secures contract for Call For Proposals Under The Framework Agreement S 2023 436 - Medicines For The Central Nervous System 2023 491 - Oncological Medicines And Immunomodulators 2023 492 - M

Portugal, May 27 -- Portugal based FRESENIUS KABI PHARMA PORTUGAL, LDA. has secured contract from Unidade Local De Saude Do Arco Ribeirinho, E.P.E. for Call For Proposals Under The Framework Agreement S 2023 436 - Medicines For The Central Nervous System 2023 491 - Oncological Medicines And Immunomodulators 2023 492 - M . The value of the contract is worth 141000 EUR .

Published by HT Digital Content Services with permission from Pivotal Sources....